Home » Topics » BioWorld Science

BioWorld Science
RSS

uniQure presents further clinical data on AMT-060 for hemophilia B

Feb. 9, 2018

Significant reductions in LDL-cholesterol seen with MGL-3196 in phase II tiral

Feb. 9, 2018

Vifor prepares to begin phase I trial of oral ferroportin inhibitor VIT-2763

Feb. 9, 2018

Implantable device allows photodynamic therapy for tumors deep in the body

Feb. 9, 2018

GlaxoSmithKline reviews milestones of fourth quarter 2017

Feb. 9, 2018

SPK-8011 shown safe and effective for hemophilia A

Feb. 9, 2018

AstraZeneca announces pipeline highlights of fourth quarter 2017

Feb. 9, 2018

ABAC Therapeutics identifies novel antibacterials

Feb. 9, 2018

Therapix Biosciences clarifies regulatory pathway for THX-110

Feb. 9, 2018

Novel ACKR3 antagonists patented by Idorsia Pharmaceuticals

Feb. 9, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 7, 2025.
House passes H.R. 1, restoring R&D tax cuts
BioWorld MedTech
The House of Representatives passed H.R. 1, also known as One Big Beautiful Bill, which will restore personal income tax cuts that expired in 2022. However, the...
With surface mimicry, molecular glues shed hairpin need
BioWorld Science
Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In targeted degradation, compounds induce...
Exercise-mimicking compound offers alternative to GLP-1 therapies
BioWorld
An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...